Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Fleiss, Bobbi ^a,d   Nilsson, Marie K L ^b   Blomgren, Klas ^b,c   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Histone deacetylase; Hypoxia ischaemia; Lipopolysaccharide; Neonatal; Trichostatin a

Indexed keywords

CASPASE 3; CHEMOKINE; COREPRESSOR PROTEIN; CXCL1 CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MICROTUBULE ASSOCIATED PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN SIZE; BRAIN TISSUE; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL MATURATION; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ACTIVATION; ENZYME INHIBITION; FEAR; FEMALE; GRAY MATTER; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LOW DRUG DOSE; MALE; MICROGLIA; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OLIGODENDROGLIA; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SEX DIFFERENCE; TREATMENT RESPONSE; WHITE MATTER;

EID: 84859790154     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-70     Document Type: Article

References (63)

1. Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, Eriksson K, Hagberg H, Mallard C. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477. 10.4049/jimmunol.0900762, 19917690.
2. Dean JM, Wang X, Kaindl AM, Gressens P, Fleiss B, Hagberg H, Mallard C. MicroglialMyD88signaling regulates acute neuronal toxicity of LPS-stimulated microgliain vitro. Brain Behav Immun 2010, 24:776-783. 10.1016/j.bbi.2009.10.018, 19903519.
3. Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp Cell Res 1999, 249:161-176. 10.1006/excr.1999.4461, 10328963.
4. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, Richon VM. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002, 99:11700-11705. 10.1073/pnas.182372299, 129332, 12189205.
5. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007, 321:892-901. 10.1124/jpet.107.120188, 17371805.
6. Shein NA, Grigoriadis N, Alexandrovich AG, Simeonidou C, Lourbopoulos A, Polyzoidou E, Trembovler V, Mascagni P, Dinarello CA, Shohami E. Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J 2009, 23:4266-4275. 10.1096/fj.09-134700, 2812044, 19723705.
7. Moreira JM, Scheipers P, Sørensen P. The histone deacetylase inhibitor trichostatin A modulates CD4+ T cell responses. BMC Cancer 2003, 3:30. 10.1186/1471-2407-3-30, 280656, 14606959.
8. Brogdon JL, Xu Y, Szabo SJ, An S, Buxton F, Cohen D, Huang Q. Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 2007, 109:1123-1130.
9. Suh HS, Choi S, Khattar P, Choi N, Lee SC. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol 2010, 5:521-532. 10.1007/s11481-010-9192-0, 3115474, 20157787.
10. McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, Forger NG, Murray EK, Nugent BM, Schwarz JM, Wilson ME. The epigenetics of sex differences in the brain. J Neurosci 2009, 29:12815-12823. 10.1523/JNEUROSCI.3331-09.2009, 2788155, 19828794.
11. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002, 22:10333-10345.
12. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin-TCF interaction. Nat Neurosci 2009, 12:829-838. 10.1038/nn.2333, 2701973, 19503085.
13. Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, Kim JM, Park DK, Kun Lee S, Kim M, Roh JK. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 2007, 26:464-472. 10.1016/j.nbd.2007.02.006, 17398106.
14. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Kinyamu H, Lu N, Gao X, Leng Y, Chuang DM, Zhang W, Lu RB, Hong JS. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 2008, 11:1123-1134. 10.1017/S1461145708009024, 2579941, 18611290.
15. Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, Lu RB, Gean PW, Chuang DM, Hong JS. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007, 149:203-212. 10.1016/j.neuroscience.2007.06.053, 2741413, 17850978.
16. Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y, Hagberg H, Blomgren K. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005, 12:162-176. 10.1038/sj.cdd.4401545, 15592434.
17. Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 1997, 41:521-529. 10.1002/ana.410410416, 9124810.
18. Dou H, Ellison B, Bradley J, Kasiyanov A, Poluektova LY, Xiong H, Maggirwar S, Dewhurst S, Gelbard HA, Gendelman HE. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci 2005, 25:8375-8385. 10.1523/JNEUROSCI.2164-05.2005, 16162919.
19. Sandner G, Host L, Angst MJ, Guiberteau T, Guignard B, Zwiller J. The HDAC inhibitor phenylbutyrate reverses effects of neonatal ventral hippocampal lesion in rats. Front Psychiatry 2011, 1:153. 3059629, 21423460.
20. Kabakus N, Ay I, Aysun S, Söylemezoglu F, Ozcan A, Celasun B. Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats. J Child Neurol 2005, 20:582-587.
21. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, Hagberg H. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001, 13:1101-1106. 10.1046/j.0953-816x.2001.01474.x, 11285007.
22. Wang X, Svedin P, Nie C, Lapatto R, Zhu C, Gustavsson M, Sandberg M, Karlsson JO, Romero R, Hagberg H, Mallard C. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 2007, 61:263-271. 10.1002/ana.21066, 17253623.
23. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124. 10.1016/S1474-4422(08)70294-1, 2707149, 19081519.
24. Hagberg H, Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005, 18:117-123. 10.1097/01.wco.0000162851.44897.8f, 15791140.
25. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8. 10.1203/00006450-199707000-00001, 9212029.
26. Renolleau S, Fau S, Goyenvalle C, Charriaut-Marlangue C. Sex, neuroprotection, and neonatal ischemia. Dev Med Child Neurol 2007, 49:477-478.
27. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G, , . International Pediatric Stroke Study Group, International Pediatric Stroke Study Group Male predominance in childhood ischemic stroke: findings from the International Pediatric Stroke Study. Stroke 2009, 40:52-57. 10.1161/STROKEAHA.108.521203, 18787197, International Pediatric Stroke Study Group, International Pediatric Stroke Study Group.
28. Nijboer CH, Kavelaars A, van Bel F, Heijnen CJ, Groenendaal F. Gender-dependent pathways of hypoxia-ischemia-induced cell death and neuroprotection in the immature P3 rat. Dev Neurosci 2007, 29:385-392. 10.1159/000105479, 17762206.
29. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 2004, 89:1358-1367. 10.1111/j.1471-4159.2004.02406.x, 15189338.
30. Svedin P, Hagberg H, Savman K, Zhu C, Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007, 27:1511-1518. 10.1523/JNEUROSCI.4391-06.2007, 17301159.
31. Mayer C, Acosta-Martinez M, Dubois SL, Wolfe A, Radovick S, Boehm U, Levine JE. Timing and completion of puberty in female mice depend on estrogen receptor α-signaling in kisspeptin neurons. Proc Natl Acad Sci USA 2010, 107:22693-22698. 10.1073/pnas.1012406108, 3012491, 21149719.
32. Yildirim F, Gertz K, Kronenberg G, Harms C, Fink KB, Meisel A, Endres M. Inhibition of histone deacetylation protects wildtype but notgelsolin-deficient mice from ischemic brain injury. Exp Neurol 2008, 210:531-542. 10.1016/j.expneurol.2007.11.031, 18234195.
33. Chia Ghee Sng J, Taniura H, Yoneda Y. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fosand c-jungenes after kainate stimulation. Neurosci Lett 2005, 386:150-155. 10.1016/j.neulet.2005.06.003, 16002216.
34. Shang Y, Jiang YX, Ding ZJ, Shen AL, Xu SP, Yuan SY, Yao SL. Valproic acid attenuates the multiple-organ dysfunction in a rat model of septic shock. Chin Med J (Engl) 2010, 123:2682-2687.
35. Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F, Moroni F, Chiarugi A. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 2006, 70:1876-1884. 10.1124/mol.106.027912, 16946032.
36. Rothstein RP, Levison SW. Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults. Dev Neurosci 2005, 27:149-159. 10.1159/000085987, 1351040, 16046849.
37. Liu J, Casaccia P. Epigenetic regulation of oligodendrocyte identity. Trends Neurosci 2010, 33:193-201. 10.1016/j.tins.2010.01.007, 2849857, 20227775.
38. Choi Y, Park SK, Kim HM, Kang JS, Yoon YD, Han SB, Han JW, Yang JS, Han G. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells andin vivoendotoxemia model. Exp Mol Med 2008, 40:574-581. 10.3858/emm.2008.40.5.574, 2679350, 18985016.
39. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, Donà G, Fossati G, Sozzani S, Azam T, Bufler P, Fantuzzi G, Goncharov I, Kim SH, Pomerantz BJ, Reznikov LL, Siegmund B, Dinarello CA, Mascagni P. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 2002, 99:2995-3000. 10.1073/pnas.052702999, 122461, 11867742.
40. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 2004, 5:392-401. 10.1038/nrm1368, 15122352.
41. Mesplès B, Plaisant F, Fontaine RH, Gressens P. Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity. Acta Paediatr 2005, 94:185-190. 10.1080/08035250410022378, 15981752.
42. Carty ML, Wixey JA, Kesby J, Reinebrant HE, Colditz PB, Gobe G, Buller KM. Long-term losses of amygdala corticotropin-releasing factor neurons are associated with behavioural outcomes following neonatal hypoxia-ischemia. Behav Brain Res 2010, 208:609-618. 10.1016/j.bbr.2010.01.007, 20085787.
43. Järlestedt K, Atkins AL, Hagberg H, Pekna M, Mallard C. Trace fear conditioning detects hypoxic-ischemic brain injury in neonatal mice. Dev Neurosci 2011, 33:222-230. 10.1159/000329710, 21778703.
44. Gibson CL, Murphy SP. Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem 2010, 115:806-813. 10.1111/j.1471-4159.2010.06993.x, 3062975, 20831615.
45. Tsai HW, Grant PA, Rissman EF. Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 2009, 4:47-53. 10.4161/epi.4.1.7288, 2667098, 19029819.
46. Mouton PR, Long JM, Lei DL, Howard V, Jucker M, Calhoun ME, Ingram DK. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res 2002, 956:30-35. 10.1016/S0006-8993(02)03475-3, 12426043.
47. Marriott I, Bost KL, Huet-Hudson YM. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J Reprod Immunol 2006, 71:12-27. 10.1016/j.jri.2006.01.004, 16574244.
48. Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, Garcia-Segura LM. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ 2011, 2:7. 10.1186/2042-6410-2-7, 3143074, 21745355.
49. Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, Chanda ML, Graham AC, Topham L, Beggs S, Salter MW, Mogil JS. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci 2011, 31:15450-15454. 10.1523/JNEUROSCI.3859-11.2011, 3218430, 22031891.
50. Davis M, Emory E. Sex differences in neonatal stress reactivity. Child Dev 1995, 66:14-27. 10.2307/1131187, 7497822.
51. Spange S, Wagner T, Heinzel T, Krämer OH. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 2009, 41:185-198. 10.1016/j.biocel.2008.08.027, 18804549.
52. Tariq M, Saze H, Probst AV, Lichota J, Habu Y, Paszkowski J. Erasure of CpG methylation inArabidopsisalters patterns of histone H3 methylation in heterochromatin. Proc Natl Acad Sci USA 2003, 100:8823-8827. 10.1073/pnas.1432939100, 166397, 12853574.
53. Huang Y, Doherty JJ, Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci 2002, 22:8422-8428.
54. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 2011, 31:52-57. 10.1038/jcbfm.2010.195, 3049473, 20978517.
55. Kim HJ, Leeds P, Chuang DM. The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 2009, 110:1226-1240. 10.1111/j.1471-4159.2009.06212.x, 2726719, 19549282.
56. Chakravortty D, Koide N, Kato Y, Sugiyama T, Mu MM, Yoshida T, Yokochi T. The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res 2000, 6:243-247.
57. Doverhag C, Hedtjärn M, Poirier F, Mallard C, Hagberg H, Karlsson A, Sävman K. Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2010, 38:36-46. 10.1016/j.nbd.2009.12.024, 20053377.
58. Perlman JM. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev 1998, 53:99-120. 10.1016/S0378-3782(98)00037-1, 10195704.
59. Liu AY, Lin Z, Choi HS, Sorhage F, Li B. Attenuated induction of heat shock gene expression in aging diploid fibroblasts. J Biol Chem 1989, 264:12037-12045.
60. Yakovlev A, Khafizova M, Abdullaev Z, Loukinov D, Kondratyev A. Epigenetic regulation of caspase-3 gene expression in rat brain development. Gene 2010, 450:103-108. 10.1016/j.gene.2009.10.008, 2795079, 19909801.
61. Espinoza CR, Feeney AJ. The extent of histone acetylation correlates with the differential rearrangement frequency of individual VHgenes in pro-B cells. J Immunol 2005, 175:6668-6675.
62. Davenport CM, Sevastou IG, Hooper C, Pocock JM. Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J Neurochem 2010, 112:552-563. 10.1111/j.1471-4159.2009.06485.x, 19895660.
63. Giza CC, Mink RB, Madikians A. Pediatric traumatic brain injury: not just little adults. Curr Opin Crit Care 2007, 13:143-152. 10.1097/MCC.0b013e32808255dc, 17327734.